A new Washington Whodunit and Giveaway: K Street Killing by Colleen J. Shogan
from A new Washington Whodunit and Giveaway: K Street Killing by Colleen J. Shogan
Higher ed has problems. Is it bad enough to quit?
Oliver Lee Bateman, who penned last year’s widely read defense of grade inflation, has finally had enough. On September 8, he published a piece titled I have one of the best jobs in academia. Here’s why I’m walking away.
His reasons:
1) Too many people go to college
…not out of any particular interest in the field, but in order to receive raises at work or improve their position in a crowded job market.
2) Online education isn’t the solution
…a grader for one of our online courses supervises approximately 30 to 50 students for an entire course. The grader typically makes $700.
3) Tenured professors pity adjuncts. But we can’t help them.
It’s not that we full-timers don’t care; it’s that we can’t.
4) “Alt-academia” isn’t a solution — it’s surrender
…when it comes time to pay it off with a real job? Sorry — best look somewhere “alternative.”
5) The students and professors aren’t the problem; the university system is.
I have my own ideas for fixing higher ed, and many of them don’t have anything to do with higher ed. Also all of them cost money.
We’re talking about it over at Higher Education’s Premier Online Publication.
Come join us!
Filed under: College Misery, Higher Ed Tagged: College Misery, context matters, Higher Ed, misery, politics
from Higher ed has problems. Is it bad enough to quit?
New BMJ editorial: “How Medicine is Broken, and How We Can Fix It”
Well documented problems exist in the funding and prioritisation of research, the conduct of trials, the withholding of results, the dissemination of evidence, and its implementation with patients. Here we briefly examine six domains where the academy could call for simple practical improvements that would address legitimate concerns.
Publication bias—We conduct trials to detect modest differences, and spend vast amounts of money specifically to exclude bias, yet we allow that bias to flood back in through selective publication.3 4 Eminent bodies writing reports will not fix this, but practical action will. We need new funding for simple systematic work to audit which trials are unreported, to highlight the best and worst performers, and to shine a light on withheld studies.5
Independent trials—A recent cohort study found that 97% of head to head trials sponsored by industry give results that favour the sponsor’s drug.6 Doctors and patients are right to want independent trials. On statins and oseltamivir, there are two clear opportunities, and here we declare our own conflicts. With colleagues, one of us (CH) first proposed a trial of oseltamivir in a pandemic in 2009; the other (BG) first proposed a trial of statins examining side effects over a year ago. In both cases we could have the answer by now.
Cost of trials—Replication will be possible only if the cost of conducting trials is radically reduced. Much of this cost is driven by disproportionate regulation around trials of routinely used treatments.7 The National Institute for Health and Care Excellence’s guidance on cholesterol argues for head to head trials in low risk populations; this would require over 100 000 participants, followed up for a decade. Such trials can practically be delivered only by reducing the expensive and disproportionate regulatory burden,7 embedding them in everyday clinical care and gathering follow-up data from existing electronic health records.8
Better evidence—Treatments are routinely approved after trials with only surrogate outcomes.9 Drugs are then extensively promoted, at the moment of approval, when evidence on real world outcomes is paradoxically at its weakest. We could encourage better evidence by, for example, compelling companies to follow-up all phase III trial participants until real world benefits emerge, considering routine randomisation for newly approved drugs when benefits are unclear, and bartering with either patent extension or choice of the start date for market exclusivity. These suggestions would come at minimal cost and deliver more comprehensive data on treatment effects.
Shared decision making—Concern over statins has recently been reawakened by the introduction of a financial incentive for general practitioners to prescribe the drugs to low risk patients. This is ill judged because patients’ informed choices vary widely.10 11 An incentive to prescribe a treatment that many adequately informed patients do not want undermines informed decision making and inflicts avoidable reputational harm on the profession. If instead we incentivise shared decision making then—for the same financial outlay—best practice will be recognised, rewarded, and laid down in the everyday templates of what doctors do.12
Declare conflicts of interest—Declaration of conflicts of interest is currently chaotic, inconsistent, and incomplete. We clearly need a central system of declarations, ideally maintained by the General Medical Council.13 Conflicts, however, become particularly salient when evidence is unclear: when decisions about which treatment works best are made on the basis of a speculative, superficially plausible narrative about a drug’s mechanism of action, or on the interpretation of weak, confounded, observational data when randomised trials are feasible. If we are able to generate better evidence and ensure that we see the complete evidence, then competing interests—although they must always be declared—will become less salient.
New BMJ editorial: “How Medicine is Broken, and How We Can Fix It”:
By Ben Goldacre
Filed under: Science! Tagged: Ben Goldacre, medicine, politics, science
from New BMJ editorial: “How Medicine is Broken, and How We Can Fix It”
GUEST POST and GIVEAWAY: The Right Kind of Skin (Rhino) by Joanne Guidoccio
In high school, Joanne Guidoccio dabbled in poetry, but it would be over three decades before she entertained the idea of writing as a career. In 2008, she took an early retirement from teaching and decided to launch a second career that would tap into her creative side and utilize her well-honed organizational skills. Before long, Joanne was a working writer; her articles and book reviews were published in newspapers, magazines, and online. Eventually she progressed to fiction, where she finds that reinvention is a recurring theme in her novels and short stories.
Today, Joanne came by to chat about having the right kind of skin. Rhino skin.
Writers especially will appreciate this:
It behooves you to develop a thicker skin.
Toastmaster Rosalind Scantlebury did not mince words at a recent Table Topics Contest. Responding to the prompt—Sticks and stones may break my bones, but words will never hurt me—she focused on an individual’s responsibility not to take things so personally. She peppered her impromptu talk with provocative comments, among them, “What other people think of you is none of your business.”
Definitely inspiring, especially for writers.
Thirty-one years of teaching adolescents thickened my skin considerably, but I faced different challenges when I embarked on a writing career. I had to learn how to deal effectively with critiques and rejection letters from agents and publishers and, most important of all, acquire that coveted rhino skin.
These are some of the strategies in my toolbox:
Get the Back Story
Whenever I attend readings, I pay special attention to the author’s back story. I like hearing the details about his or her writing journey and the challenges encountered along the way. Occasionally, I pick up valuable nuggets of advice that help me along my own journey. For example, Guelph writer Nicholas Ruddock (The Parabolist) established his platform by entering and placing in short story contests. When New York Times bestselling author Louise Penny couldn’t find a Canadian or American agent, she crossed the pond and approached a British agent.
Read Bad Reviews
If I have enjoyed reading a book, I look up the one-star reviews on Amazon. That’s right, I gravitate toward the negative. While shaking my head at the nitpicking and negative comments, I realize that no author is immune from criticism. Not even authors of best-selling novels can please everyone.
Eliminate the Negative
Some writers file and keep all their rejection letters. I suspect they refer to these letters often and get discouraged all over again. It is important to keep accurate records, but it is not necessary to keep these negative reminders around for future reference. After reading a rejection letter, I update the information on a spreadsheet and delete the file.
Throw More Irons Into the Fire
We’ve all heard the advice. Send out the manuscript and then immediately start on another one. Easier said than done. After writing 70K words and looking at multiple drafts of that manuscript, the thought of starting all over again can be daunting. Instead, I like to work on shorter pieces: book reviews, short stories, articles, more blog posts. Entering contests and taking online writing courses also keep my skills sharp. It is important not to sit around waiting for a response. Some action—any action—is needed.
Get Support
I belong to Crime Writers of Canada, Sisters in Crime, Guppies, and Romance Writers of America. I also participate in discussion boards for The Wild Rose Press and Soul Mate Publishing Authors. I try to attend writing workshops, panels and readings offered within a fifty-mile radius. While interacting with these authors, I get valuable advice and feedback about my work. I appreciate all the help I have received, especially from good friend and fellow writer Patricia Anderson. I had only request: “Let it rip!” And she did, but in a constructive way.
From Toronto based freelancer Ian Harvey…
“Rejections are part of the game, but this is the only game in which rejection doesn’t mean no. It means not now, or not for me, or not for me right now. It doesn’t mean no forever.”
Get Joanne’s latest, A Season for Killing Blondes.
And the giveaway:
Enter to win a $25 Amazon gift card!
Follow Joanne:
Website/Twitter/Facebook/LinkedIn/Pinterest/Goodreads/Book Trailer
BE THE FIRST TO LEARN ABOUT PROMOTIONS, EVENTS, AND NEW RELEASES:
THE MUSUBI MURDER August 2015 Amazon / B&N /Powell’s /Audible / iTunes
Filed under: Author Interviews, Buy, Fun, Writing Tagged: Amazon, book spotlight, career advice, context matters, cozy mystery, funny, Joanne Guidoccio, Mystery, politics, rhino skin, Writing
from GUEST POST and GIVEAWAY: The Right Kind of Skin (Rhino) by Joanne Guidoccio
Study: Fat Cat Professors Not Responsible for Rising Tuition, May Not Actually Exist
Between 78 and 79 percent of the tuition hikes at public universities -- which averaged $3,628 per student at research universities and $2,463 per student at nonresearch colleges -- was due to declining state appropriations, between 5 and 6 percent was due to increased administrative spending, and another 6 percent was due to construction costs.Report says administrative bloat, construction booms not largely responsible for tuition increases | InsideHigherEd.
